By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our
Privacy Policy
for more information.
Accept
Deny
Preferences
Privacy
Privacy Preferences
Essential cookies
Required
Marketing cookies
Essential
Personalization cookies
Essential
Analytics cookies
Essential
Allow all cookies
Reject all cookies
Save preferences
Follow Us:
Subscribe
Thank you!
Oops!
Submit
About Proxima
Meet our Team
Why Proxima
Careers
We
Innovators
Our Expertise
Solutions
Regulatory
Clinical
Biotech
MedTech
Therapeutic Areas
Oncology
Pediatric
Cardiovascular
Orthopedics & Spine
Neuromodulation
General Surgery
In Vitro Diagnostics
Resources
Company updates
Newsletter
Company News
Press & Media
Webinars & Podcasts
Events
All Posts
Knowledge base
Industry Articles
FAQs
Glossary
Tools & Templates
Video Hub
Breakthrough Device Designation
Accelerator
Submit RFP
Submit RFP
Subscribe to Our
Newsletter!
Industry News & Company Updates
Past Newsletters
Newsletter: Poison Pills & Contingency Plans | April 26th, 2022
Cath up on Elon Musk's Twitter purchase saga and tune into In local news - it’s an exciting time to be a life sciences company in Houston right now. Learn why with Kevin Coker!
April 2022
Newsletter: Twitter, Tesla & Things Not to Do Unless You are a Trillionaire (on a Tuesday no less) | April 12th, 2022
Let's review the tale of a tech billionaire and Twitter with Proxima's CEO, Kevin Coker.
April 2022
Newsletter: RoboPills & Sunscreen Smoothies | March 29th, 2022
Learn what Proxima CRO has been up to this past month!
March 2022
Newsletter: Curing Mouse Cancer + J&J’s Secret Asbestos Trial | March 15th, 2022
Learn the latest on investing, innovating, and upcoming MedTech and biotech events in March!
March 2022
Newsletter: MedTech Marvels & A New HIV Cure | February 28th, 2022
Learn the latest on investing, innovating, and upcoming MedTech and biotech events in March!
February 2022
Newsletter: We <3 Innovators | February 14th, 2022
Learn the latest on investing, innovating, and our new resources about Breakthrough Device Designation and Texas Life Sciences Forum in Houston, Texas this month!
February 2022
Newsletter: Cyber Drugs & The Biotech Bear | February 1st, 2022
Learn the latest on investing, innovating, and our new resources about Breakthrough Device Designation and the Special 510(k) program!
February 2022
Newsletter: New Year, New Pills | January 5th, 2022
Stay up-to-date with the latest in healthcare releases, innovations, breakthroughs, and more!
January 2022
Newsletter: Hi-Tech, Humblebrags, and Hype Unraveled | December 20th, 2021
Stay up-to-date with the latest in healthcare releases, innovations, breakthroughs, and more!
December 2021
Previous
Next
